# Actuate Therapeutics, Inc.: Form 8-K, filed Jul 17, 2026

- Company: [Actuate Therapeutics, Inc.](/companies/actu.md) (CIK 1652935)
- Form: 8-K
- Filed: 2026-07-17
- Accepted by EDGAR: Jul 17, 2026, 16:30 ET
- Period: 2026-07-15
- Accession: 0001683168-26-005616
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/actuate_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/actuate_8k.htm

Filed Jul 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-005616. Last ingested by Listed: Nov 2, 2026, 18:06 ET. No prices; not investment advice.